Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar and appetite signals in the brain. The FDA-approved maximum dose for Wegovy is 2.4 mg injected once weekly, but clinical evidence shows meaningful weight loss begins at much lower doses. Understanding how semaglutide works and what dose levels are available can help you make an informed decision about treatment.
What Is the Maximum Dose of Wegovy?
The highest FDA-approved dose of Wegovy is 2.4 mg administered as a single subcutaneous injection once per week. Patients typically begin at 0.25 mg weekly and increase gradually over 16 weeks to reach this maintenance dose, a protocol called titration. This gradual escalation helps the body adapt and reduces the risk of gastrointestinal side effects.
Not every patient requires the 2.4 mg maximum dose to achieve their weight loss goals. Clinical trial data from STEP 1 showed that participants using the 2.4 mg dose lost an average of 14.9% of body weight over 68 weeks, but earlier dose cohorts also demonstrated significant reductions. Many individuals reach their target weight loss at 1.7 mg or 2.0 mg, meaning they may stop the dose escalation before reaching the maximum.
PlexusDx compounded semaglutide injections are customizable at any dose level your prescriber determines is right for you. Unlike Wegovy, which comes in pre-filled pens at fixed doses, compounded medications can be precisely tailored to your body and treatment response. Your dose may increase over time, but PlexusDx pricing remains flat regardless of dose level—starting at $149 per month.
How Does Semaglutide Work in Your Body?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it binds to GLP-1 receptors in the brain and digestive system. When activated, these receptors send signals that slow stomach emptying, increase feelings of fullness, and reduce hunger-driven eating behaviors. This mechanism is rooted in the body's natural appetite control system, not artificial stimulation or metabolism boosting.
The medication also influences blood sugar regulation by stimulating insulin secretion when glucose levels are elevated and suppressing glucagon release when they are low. This dual action on appetite and glucose management is why semaglutide has shown benefits beyond weight loss, including improved metabolic markers in patients with obesity and type 2 diabetes. The effects typically develop over the first few weeks of treatment as the dose increases.
Individual response to semaglutide varies based on genetics, lifestyle, and metabolic factors. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants in the GLP1R, GIPR, FTO, and MC4R genes to identify your peptide pathway profile. This testing can help predict your likelihood of response and optimize your personalized treatment plan before starting or adjusting therapy.
Understanding Semaglutide Dosing Schedules and Titration
Standard Wegovy titration begins at 0.25 mg weekly for 4 weeks, then increases by 0.25 mg every 4 weeks until reaching the target maintenance dose. This 16-week escalation period allows your gastrointestinal system to adapt and helps you find the lowest effective dose for your goals. Some patients feel satisfied at 0.5 mg or 1.0 mg and never need to progress further.
Dose escalation is not one-size-fits-all. Your healthcare provider may recommend pausing at a particular dose level if you are experiencing significant side effects, or slowing the titration schedule if your body needs more time to adjust. Conversely, some patients tolerate rapid escalation and progress to higher doses without difficulty. Regular check-ins with your PlexusDx provider ensure your dose strategy matches your individual tolerance and weight loss trajectory.
Once you reach your target maintenance dose, you continue that dose weekly for as long as you remain on treatment. If you pause semaglutide or stop treatment, appetite signals and hunger typically return within weeks, which is why ongoing medication use is necessary to sustain weight loss. PlexusDx supports continuous access with no membership fees or insurance requirements, making long-term adherence more affordable.
Compounded Semaglutide vs. Wegovy: Cost and Access Differences
Wegovy brand-name pens typically cost $1,300–$1,500 per month without insurance coverage and may require prior authorization or have limited formulary coverage even with pharmacy insurance. Many patients face out-of-pocket maximums, copays, or outright denials from their insurance plans. This financial barrier has driven demand for compounded alternatives that offer the same active ingredient at a fraction of the cost.
PlexusDx compounded semaglutide injections start at $149 per month across three commitment tiers and remain that flat price regardless of your dose—whether you are at 0.5 mg or 2.4 mg. No insurance is required, no membership fees apply, and the medication is HSA/FSA eligible. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies and serves all 50 states, ensuring legal, regulated access to affordable treatment.
Compounded semaglutide contains the same FDA-active pharmaceutical ingredient as Wegovy but is prepared in a regulated compounding pharmacy rather than a commercial manufacturing facility. This means the medication itself is not FDA-approved, but the compounding process is state and federally regulated for safety and potency. Many patients find compounded semaglutide equally effective as the branded version at a significantly lower out-of-pocket cost.
Common Side Effects at Different Dose Levels
Gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation are the most commonly reported adverse events during semaglutide titration. These effects tend to be mild to moderate, peak during the first few weeks at each new dose, and often resolve as your body adapts. Taking the injection with food, staying hydrated, and eating smaller meals can help minimize discomfort.
Rare but serious side effects include pancreatitis (inflammation of the pancreas), gallbladder issues, and thyroid concerns in patients with a personal or family history of medullary thyroid cancer. Your PlexusDx provider will screen for contraindications before starting treatment and monitor you throughout therapy. If you experience persistent severe abdominal pain, vision changes, or signs of dehydration, contact your provider immediately.
Most patients report that side effects are temporary and manageable compared to the substantial weight loss benefits they achieve. Studies show that gastrointestinal tolerability improves once patients reach their target maintenance dose and their body fully acclimates to semaglutide. Maintaining adequate nutrition, electrolyte balance, and hydration supports better overall tolerability.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I stay on a dose lower than 2.4 mg and still lose weight with semaglutide?
Yes, absolutely. Clinical evidence shows meaningful weight loss at doses as low as 0.5 mg to 1.7 mg weekly. Many patients reach their personal weight loss goals and choose to remain at a lower maintenance dose rather than titrate to the 2.4 mg maximum. Your PlexusDx provider will help you find the optimal dose for your needs.
How long does it take to see weight loss results on semaglutide?
Most patients notice appetite suppression within 1–2 weeks of starting semaglutide. Measurable weight loss typically becomes apparent after 4–6 weeks of consistent use. Average weight loss accelerates as you titrate to higher doses, with full benefit usually evident after 12–16 weeks of treatment.
Why is PlexusDx compounded semaglutide so much cheaper than Wegovy?
PlexusDx partners with licensed 503A compounding pharmacies to prepare semaglutide in bulk, bypassing the high manufacturing and marketing costs of brand-name Wegovy. Compounded medications are not subject to the same patent protections, allowing PlexusDx to pass savings directly to patients. Starting at $149/month with no insurance required, PlexusDx makes semaglutide accessible to many more people.
Is compounded semaglutide as safe and effective as Wegovy?
Compounded semaglutide contains the identical active pharmaceutical ingredient as Wegovy and is prepared in state and federally regulated compounding pharmacies under strict quality standards. The main difference is manufacturing location and cost; clinical efficacy is equivalent. Your PlexusDx provider will monitor your progress just as closely as with the brand version.
How can PlexusDx's genetic testing help me optimize my semaglutide dose?
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence your appetite regulation and weight loss potential. Understanding your genetic peptide profile helps your provider predict your likely response to semaglutide and tailor your titration schedule for faster, safer progress toward your goals.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Health Journey: Can You Take Ozempic With Cholesterol Medicine?
Optimizing Your Zepbound Schedule: Can You Take It 1 Day Early?